← SynDRA
OSI-027
SynDRA canonical compound SYN0037823 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | MTOR |
| Mechanism of action | MTOR inhibitor |
All known targets
Mechanisms of action (all sources)
- MAPK8 INHIBITOR
- MTOR inhibitor
- Serine/threonine-protein kinase mTOR inhibitor
Cross-references
Synonyms
- AEVI-006
- ASP-7486
- ASP7486
- CERC-006
- CERC006
- OSI027
- (+/-)-Cyclohexanecarboxylic acid, 4-(4-amino-5-(7-methoxy-1H-indol-2-yl)imidazo(5,1-f)(1,2,4)triazin-7-yl)-, trans-
- (1r,4r)-4-(4-Amino-5-(7-methoxy-1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl)cyclohexane-1-carboxylic acid
- (1r,4r)-4-(4-amino-5-(7-methoxy-1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl)cyclohexanecarboxylic acid
- (1r,4r)-4-(4-Amino-5-(7-methoxy-1H-indol-2-yl)imidazo-[5,1-f][1,2,4]triazin-7-yl)cyclohexanecarboxylic acid
- 25MKH1SZ0M
- 4-(4-Amino-5-(7-methoxy-1H-indol-2-yl)imidazo[5,1-f] [1,2,4]Triazin-7-yl)cyclohexanecarboxylic Acid
- 4-[(5Z)-4-amino-5-(7-methoxyindol-2-ylidene)-1H-imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexane-1-carboxylic acid
- 4-[4-amino-5-(7-methoxy-1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexane-1-carboxylic acid
- 4-[4-amino-5-(7-methoxy-2-indolylidene)-1H-imidazo[5,1-f][1,2,4]triazin-7-yl]-1-cyclohexanecarboxylic acid
- 936890-98-1 (free acid)
- A-1065
- AC-31517
- AKOS030238938
- AKOS037643584
- AM81260
- AS-17003
- ASP4786
- BCP02613
- BCP9001034
- BDBM185151
- BRD-K94294671-003-01-3
- CCG-268721
- CHEBI:91363
- CHEMBL2132692
- CHEMBL3120215
- CS-0257
- Cyclohexanecarboxylic acid, 4-(4-amino-5-(7-methoxy-1H-indol-2-yl)imidazo(5,1-f)(1,2,4)triazin-7-yl)-, trans-
- Cyclohexanecarboxylic acid, 4-[4-amino-5-(7-methoxy-1h-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl]-, trans-
- DB12387
- DTXSID901025951
- EX-A143
- F17371
- HMS3656H05
Look up OSI-027 in the interactive SynDRA portal →